174 related articles for article (PubMed ID: 29325275)
1. [Qualitative pathological assessment of liver fibrosis regression after antiviral therapy in patients with chronic hepatitis B].
Sun YM; Zhou JL; Wang L; Wu XN; Chen YP; Piao HX; Lu LG; Jiang W; Xu YQ; Feng B; Nan YM; Xie W; Chen GF; Zheng HW; Li H; Ding HG; Liu H; Lyu FD; Shao C; Wang TL; Ou XJ; Wang BQ; Chen SY; You H; Jia JD
Zhonghua Gan Zang Bing Za Zhi; 2017 Nov; 25(11):819-826. PubMed ID: 29325275
[No Abstract] [Full Text] [Related]
2. Early steep decline of liver stiffness predicts histological reversal of fibrosis in chronic hepatitis B patients treated with entecavir.
Kong Y; Sun Y; Zhou J; Wu X; Chen Y; Piao H; Lu L; Ding H; Nan Y; Jiang W; Xu Y; Xie W; Li H; Feng B; Shi G; Chen G; Li H; Zheng H; Cheng J; Wang T; Liu H; Lv F; Shao C; Mao Y; Sun J; Chen T; Han T; Han Y; Wang L; Ou X; Zhang H; Jia J; You H
J Viral Hepat; 2019 May; 26(5):576-585. PubMed ID: 30624000
[TBL] [Abstract][Full Text] [Related]
3. Histological outcome for chronic hepatitis B patients treated with entecavir vs lamivudine-based therapy.
Wang JL; Du XF; Chen SL; Yu YQ; Wang J; Hu XQ; Shao LY; Chen JZ; Weng XH; Zhang WH
World J Gastroenterol; 2015 Aug; 21(32):9598-606. PubMed ID: 26327767
[TBL] [Abstract][Full Text] [Related]
4. New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment.
Sun Y; Zhou J; Wang L; Wu X; Chen Y; Piao H; Lu L; Jiang W; Xu Y; Feng B; Nan Y; Xie W; Chen G; Zheng H; Li H; Ding H; Liu H; Lv F; Shao C; Wang T; Ou X; Wang B; Chen S; Wee A; Theise ND; You H; Jia J
Hepatology; 2017 May; 65(5):1438-1450. PubMed ID: 28027574
[TBL] [Abstract][Full Text] [Related]
5. Liver fibrosis showed a two-phase regression rate during long-term anti-HBV therapy by three-time biopsies assessments.
Chen S; Zhou J; Wu X; Meng T; Wang B; Liu H; Wang T; Zhao X; Zhao X; Kong Y; Ou X; Jia J; Sun Y; You H
Hepatol Int; 2024 Jun; 18(3):904-916. PubMed ID: 38565833
[TBL] [Abstract][Full Text] [Related]
6. The utility of P-I-R classification in predicting the on-treatment histological and clinical outcomes of patients with hepatitis B and advanced liver fibrosis.
Chang X; Lv C; Wang B; Wang J; Song Z; An L; Chen S; Chen Y; Shang Q; Yu Z; Tan L; Li Q; Liu H; Jiang L; Xiao G; Chen L; Lu W; Hu X; Dong Z; Chen Y; Sun Y; Wang X; Li Z; Chen D; You H; Jia J; Yang Y
Hepatology; 2024 Feb; 79(2):425-437. PubMed ID: 37611260
[TBL] [Abstract][Full Text] [Related]
7. Long-term lamivudine treatment achieves regression of advanced liver fibrosis/cirrhosis in patients with chronic hepatitis B.
Xu B; Lin L; Xu G; Zhuang Y; Guo Q; Liu Y; Wang H; Zhou X; Wu S; Bao S; Cai W; Xie Q
J Gastroenterol Hepatol; 2015 Feb; 30(2):372-8. PubMed ID: 25167956
[TBL] [Abstract][Full Text] [Related]
8. Interpretation of liver stiffness measurement-based approach for the monitoring of hepatitis B patients with antiviral therapy: A 2-year prospective study.
Liang X; Xie Q; Tan D; Ning Q; Niu J; Bai X; Chen S; Cheng J; Yu Y; Wang H; Xu M; Shi G; Wan M; Chen X; Tang H; Sheng J; Dou X; Shi J; Ren H; Wang M; Zhang H; Gao Z; Chen C; Ma H; Chen Y; Fan R; Sun J; Jia J; Hou J
J Viral Hepat; 2018 Mar; 25(3):296-305. PubMed ID: 29080299
[TBL] [Abstract][Full Text] [Related]
9. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.
Chang TT; Liaw YF; Wu SS; Schiff E; Han KH; Lai CL; Safadi R; Lee SS; Halota W; Goodman Z; Chi YC; Zhang H; Hindes R; Iloeje U; Beebe S; Kreter B
Hepatology; 2010 Sep; 52(3):886-93. PubMed ID: 20683932
[TBL] [Abstract][Full Text] [Related]
10. On-treatment changes of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein are associated with the regression of liver fibrosis in chronic hepatitis B patients on interferon α add-on therapy.
Liu T; Sun Y; Zhou J; Yang F; Zou X; Wang L; Wu X; Chen Y; Piao H; Lu L; Jiang W; Xu Y; Feng B; Nan Y; Xie W; Chen G; Zheng H; Li H; Ding H; Liu H; Wang T; Ou X; Wu S; Kong Y; Wang P; Cong M; Zhang Y; You H; Jia J
J Med Virol; 2019 Aug; 91(8):1499-1509. PubMed ID: 30905065
[TBL] [Abstract][Full Text] [Related]
11. Histopathology and the predominantly progressive, indeterminate and predominately regressive score in hepatitis C virus patients after direct-acting antivirals therapy.
Huang R; Rao HY; Yang M; Gao YH; Wang J; Jin Q; Ma DL; Wei L
World J Gastroenterol; 2021 Feb; 27(5):404-415. PubMed ID: 33584072
[TBL] [Abstract][Full Text] [Related]
12. Declining in liver stiffness cannot indicate fibrosis regression in patients with chronic hepatitis B: A 78-week prospective study.
Dong XQ; Wu Z; Li J; Wang GQ; Zhao H;
J Gastroenterol Hepatol; 2019 Apr; 34(4):755-763. PubMed ID: 30290019
[TBL] [Abstract][Full Text] [Related]
13. Persistent steatosis correlates with decreased fibrosis regression during anti-HBV treatment in patients with chronic HBV infection.
Zhang M; Chen S; Wu X; Zhou J; Wang T; Liu H; Zhao X; Wang B; Zhao X; Kong Y; Soon GST; Ou X; Jia J; Chen W; Sun Y; You H
J Med Virol; 2023 Oct; 95(10):e29156. PubMed ID: 37822064
[TBL] [Abstract][Full Text] [Related]
14. Relationship between virological response and FIB-4 index in chronic hepatitis B patients with entecavir therapy.
Li N; Xu JH; Yu M; Wang S; Si CW; Yu YY
World J Gastroenterol; 2015 Nov; 21(43):12421-9. PubMed ID: 26604649
[TBL] [Abstract][Full Text] [Related]
15. Regression of Liver Fibrosis in Patients on Hepatitis B Therapy Is Associated With Decreased Liver-Related Events.
Sun Y; Chen W; Chen S; Wu X; Zhang X; Zhang L; Zhao H; Xu M; Chen Y; Piao H; Li P; Li L; Jiang W; Li X; Xing H; Liu X; Zhang Y; Wang B; Zhou J; Meng T; Zhao X; Shao C; Kong Y; Zhao X; Ou X; Liu C; Jia J; You H
Clin Gastroenterol Hepatol; 2024 Mar; 22(3):591-601.e3. PubMed ID: 38040276
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal monitoring of liver fibrosis status by transient elastography in chronic hepatitis B patients during long-term entecavir treatment.
Wu SD; Liu LL; Cheng JL; Liu Y; Cheng LS; Wang SQ; Ma W; Chen LP; Tseng YJ; Wang JY; Shen XZ; Jiang W
Clin Exp Med; 2018 Aug; 18(3):433-443. PubMed ID: 29696462
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Telbivudine Treatment Results in Resolution of Liver Inflammation and Fibrosis in Patients with Chronic Hepatitis B.
Hou JL; Xu D; Shi G; Wan M; Goodman Z; Tan D; Xie Q; Chen C; Wei L; Niu J; Wang Q; Ren H; Wang Y; Jia J; Bao W; Dong Y; Trylesinski A; Naoumov NV
Adv Ther; 2015 Aug; 32(8):727-41. PubMed ID: 26329749
[TBL] [Abstract][Full Text] [Related]
18. Quantitative assessment of liver fibrosis (qFibrosis) reveals precise outcomes in Ishak "stable" patients on anti-HBV therapy.
Sun Y; Zhou J; Wu X; Chen Y; Piao H; Lu L; Ding H; Nan Y; Jiang W; Wang T; Liu H; Ou X; Wee A; Theise ND; Jia J; You H
Sci Rep; 2018 Feb; 8(1):2989. PubMed ID: 29445243
[TBL] [Abstract][Full Text] [Related]
19. Clinical and histopathological features of chronic hepatitis B virus infected patients with high HBV-DNA viral load and normal alanine aminotransferase level: A multicentre-based study in China.
Xing YF; Zhou DQ; He JS; Wei CS; Zhong WC; Han ZY; Peng DT; Shao MM; Sham TT; Mok DK; Chan CO; Tong GD
PLoS One; 2018; 13(9):e0203220. PubMed ID: 30180183
[TBL] [Abstract][Full Text] [Related]
20. Peg-interferon improves liver histology in patients with HBeAg-positive chronic hepatitis B: no additional benefit of combination with lamivudine.
van Zonneveld M; Zondervan PE; Cakaloglu Y; Simon C; Akarca US; So TM; Flink HJ; de Man RA; Schalm SW; Janssen HL;
Liver Int; 2006 May; 26(4):399-405. PubMed ID: 16629642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
